One Health News

 
Search News:
 
Found 910 Matching Results. View archived News Here.

A One Health Initiative team co-founder discusses aspects of One Health concept - Tuesday, August 29, 2017

A One Health Initiative team co-founder discusses aspects of One Health concept

 Production of LabAnimal www.nature.com/laban

 One Health With Laura Kahn

 

Please listen to https://soundcloud.com/dustin-graham-396053697/one-health-with-laura-kahn (20 minutes 50 seconds podcast)

 

“An interview with Laura Kahn , co-founder of the One Health Initiative, and author of "One Health and the Politics of Antimicrobial Resistance".  Laura describes the gaps between human, animal, and environmental health, and the importance of bridging them through the One Health concept.”

 

 
  kahn_laura-2


Laura H. Kahn, MD, MPH, MPP

Research Scholar
Program on Science and Global Security
Woodrow Wilson School of Public and International Affairs
Princeton University

Co-Founder, One Health Initiative 
http://www.onehealthinitiative.com

Columnist, Bulletin of the Atomic Scientists
http://www.thebulletin.org

Follow on Twitter

@LauraKahn1

Dr. Kahn https://goo.gl/9aaHW7 is a national (USA) and internationally recognized physician One Health leader and spokesperson for the One Health Initiative Autonomous pro bono Team: Laura H. Kahn, MD, MPH, MPP ▪ Bruce Kaplan, DVM ▪ Thomas P. Monath, MD ▪ Lisa A. Conti, DVM, MPH.


Salmonella outbreaks linked to backyard poultry [Requires One Health approach] - Thursday, August 24, 2017

Home

 

Salmonella outbreaks linked to backyard poultry

 

Deborah Bloch, M.D., FAAP and Larry K. Pickering, M.D., FIDSA, FPIDS, FAAP

 

08/24/2017

 

Salmonella outbreaks linked to backyard poultry [Requires One Health approach]

 

“In a collaborative effort, the CDC, multiple states and the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service are investigating the outbreaks, which span 48 states and the District of Columbia (see map). Dates of illness so far include Jan. 4 to June 20, 2017. Of the 580 people with available data, 174 were hospitalized; there were no deaths. As of June 1, 36% of cases were children younger than 5 years of age. ...”

 

“... Backyard flocks highlight the need to implement an important public health measure referred to as the One Health Initiative (www.onehealthinitiative.com). This initiative requires collaborative efforts among multiple disciplines (physicians, veterinarians and other health care professionals) at different levels to improve the health of children, adults, animals and the environment. ...”

 

Read complete article at http://www.aappublications.org/news/2017/08/24/MMWR082417


Report of the One Health Technical and Ministerial Meeting to Address Zoonotic Diseases and Related Public Health Threats - Monday, August 21, 2017

reliefweb

20 Aug 2017

Report of the One Health Technical and Ministerial Meeting to Address Zoonotic Diseases and Related Public Health Threats

Report from World Health Organization

Published on 18 Aug 2017 — View Original

 http://img.static.reliefweb.int/modules/file/icons/application-pdf.pngDownload PDF (969.13 KB)

EXECUTIVE SUMMARY

The “One Health” concept underway in West Africa aims to adopt a holistic approach in responding to possible public health events such as high-impact infectious diseases emerging at the interface between humans, animals and the environment. A technical and ministerial meeting was convened at the Radisson Blu Hotel in Dakar, Senegal, from 8 to 11 November 2016 to share experiences and explore challenges encountered during the One Health approach to fight zoonosis and related public health threats. ...

Read full article at http://reliefweb.int/report/world/report-one-health-technical-and-ministerial-meeting-address-zoonotic-diseases-and


One Health Initiative |Policy Support and Governance| Food and Agricultural Organization (FAO) of the United Nations - Saturday, August 19, 2017

One Health Initiative |Policy Support and Governance| Food and Agricultural Organization (FAO) of the United Nations ...

 

The One Health Initiative is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, ...

See: www.fao.org/policy-support/mechanisms/mechanisms-details/en/c/448751/


Why Support One Health implementation? - Tuesday, August 15, 2017

Why support One Health implementation?

 

  • One Health Advancements/justifications for implementation (43 examples—tip of the iceberg!)

http://www.onehealthinitiative.com/publications/ONE%20HEALTH%20a%20significant%20international%20public%20health%20comparative%20medicine%20OHI%20POSTING%20May%2013%202015.pdf or see https://goo.gl/3n54Bw.

 

  • One Health Endorsements:

See http://www.onehealthinitiative.com/supporters.php and http://www.onehealthinitiative.com/publications/One%20Health%20Endorsements%20June%202011%20to%20December%202015.pdf or https://goo.gl/FTKrQJ

 


Reminder! Second Annual Global One Health Day - November 3, 2017 - Monday, August 14, 2017

OHDd_def_banners_3nov_720x300

Reminder!

Second Annual Global One Health Day 2017

November 3, 2017 

   2017 One Health Day Press Release  

Remember to plan your event for 2017 One Health Day!

https://goo.gl/OIfN3E 

 See the 2016 One Health Day Event Map (https://goo.gl/AWKZwg) and descriptions of over 156 events in over 35 countries. Anyone can plan and implement a One Health Day event and it doesn't have to fall right on November 3.  Student Event Competition Awards of $2,000 each will go to one winning team in each of four global regions.

Register your event! Get on the  OH Day 2017 map!

 

87 days and counting!


World experts in One Health contribute to new Checklist for One Health Epidemiological Reporting of Evidence (COHERE) - Wednesday, August 09, 2017

World experts in One Health contribute to new Checklist for One Health Epidemiological Reporting of Evidence (COHERE)

 

Submitted to the One Health Initiative website August 2, 2017 by:

 Meghan Frost Davis

*Meghan F. Davis, DVM, MPH, PhD                                       

https://www.jhsph.edu/faculty/directory/profile/3059/meghan-frost-davis 
Assistant Professor
Department of Environmental Health and Engineering
Johns Hopkins Bloomberg School of Public Health (USA)
mdavis65@jhu.edu

 

https://i.ytimg.com/vi/5c9OaQopE_A/hqdefault.jpg?sqp=-oaymwEXCNACELwBSFryq4qpAwkIARUAAIhCGAE=&rs=AOn4CLC6IOwYCzA3lfGQBIYYTdd847fWjQ

**Peter M. Rabinowitz, MD, MPH

http://deohs.washington.edu/faculty/rabinowitz_peter

Associate Professor

Department of Environmental and Occupational Health Sciences

Department of Global Health, Department of Family Medicine

Division of Allergy and Infectious Disease (adjunct)

University of Washington School of Public Health, School of Medicine

Director, Center for One Health Research (USA)

Peterr7@uw.edu

 

A world-renowned group of ten experts http://deohs.washington.edu/cohr/cohere-expert-review-group contributed to the design of the newly-reported Checklist for One Health Epidemiological Reporting of Evidence (COHERE), recently published by the journal One Health http://www.sciencedirect.com/science/article/pii/S2352771417300022.  This tool consists of a set of 19 standards for components that should be included in the conduct and reporting of One Health studies that use observational or interventional epidemiological designs.  It also aims to promote the concept that One Health studies should integrate data from humans, animals, and their environment.  Therefore, experts were included to represent aspects of all three of these domains.

“The expert participants' perspectives enriched the tool by the very nature of addressing their experiences across disciplines,” noted Dr. Lisa A. Conti https://goo.gl/MLVRk1, a veterinarian member of the One Health Initiative Autonomous pro bono team www.onehealthinitiative.com, the 2017 recipient of the prestigious American Veterinary Epidemiology Society’s (AVES) KF Meyer/James H. Steele Gold Headed Cane Award https://goo.gl/3yaCpK, and internationally recognized One Health leader, who was a co-author on the manuscript.   Dr. Conti added, “...their thoughtful consideration of a unified approach was critical to refining the tool.”  Inclusion of many experts in the process was essential to make the tool flexible to researchers who represent a wide variety of professions and disciplines.

The authors of the manuscript and the expert review group agreed that COHERE should be a living document—one that could be amended to respond to the inclusion of new disciplines, technologies, and ideas. They encourage editors, reviewers, authors, and readers of the One Health literature to contact the COHERE team with suggestions.

 

*Dr. Davis, a veterinarian, is listed on the One Health Initiative website’s Supporters page http://www.onehealthinitiative.com/supporters.php.

**Dr. Rabinowitz, is a longstanding physician member of the One Health Initiative team’s Advisory Board http://www.onehealthinitiative.com/advBoard.php.


‘One Health in Action’...2017 American Academy of Dermatology (physicians, veterinarians and other health scientists) – New York, N.Y. - Saturday, August 05, 2017

‘One Health in Action’...2017 American Academy of Dermatology (physicians, veterinarians and other health scientists) – New York, N.Y.

“Future research collaborations between veterinarians and physician scientists to improve the treatment for chronic itch and atopic dermatitis will result in a better understanding of pathophysiology and treatment responses for humans and canines alike. This is truly the spirit of One Health.”

Jennifer M. Gardner, MD

Assistant Professor, Division of Dermatology

University of Washington

Collaborating Member, UW Center for One Health Research (COHR) http://deohs.washington.edu/cohr/

Seattle Cancer Care Alliance, Melanoma and Skin Oncology

https://www.seattlecca.org/physicians/jennifer-m-gardner

Provided by Dr. Gardner to the One Health Initiative website August 4, 2017.

 cid:image001.jpg@01D30D04.44D55BE0

Left to right:  Jennifer Gardner, MD; Daniel Morris, DVM, MPH; Elizabeth Grice, PhD; Kathryn Rook, VMD; Charles Bradley, VMD; Brian Kim, MD.  Not pictured: Dirk Elston, MD.

  

At the 2017 American Academy of Dermatology Summer meeting held in New York City, the new forum entitled “Comparative Dermatology: cases at the intersection of human and veterinary [medical] dermatology and the One Health Paradigm” featured physician dermatologists, veterinarian dermatologists and dermatopathologists and scientists at the podium and asked how can a collaborative approach across these disciplines help us understand our own skin health better? The forum was conceived through collaboration between Dr. Jennifer Gardner, Assistant Professor of Dermatology at the University of Washington in Seattle and Collaborating Member of the UW Center for One Health Research and Dr. Dan Morris, Professor of Dermatology & Allergy at the University of Pennsylvania School of Veterinary Medicine. Dr. Gardner provided a short introduction defining “One Health” for the audience and described how using the One Health paradigm can reveal connections between human health, animals and the shared environment. Then three pairs of experts explored topics as they related to OH and dermatology.

First up, Dr. Dirk Elston, Chairman of Dermatology at the Medical University of South Carolina, shared an update regarding Demodex, a.k.a. “the follicle mite, in humans, including skin disorders associated with overgrowth of this usually symbiotic ectoparasite. He also discussed treatment of these problems when our mites are behaving badly. His favorite therapy turns out to be an oldie but still goodie: sulfur.

Dr. Kathryn Rook, a veterinary [medical] dermatologist at the University of Pennsylvania School of Veterinary Medicine, shared news about a revolution in veterinary [medical] clinics regarding treatment of Demodex mites in dogs and cats, which are not zoonotic, meaning demodectic mange doesn’t get passed from family pets to their humans. Considering the veterinary [medical] world is decades ahead of human medicine with regard to anti-ectoparasitic strategies, it’s worth looking to veterinarians to see what might be coming down the pipeline for humans. A new class of drugs currently licensed in the U.S. for flea and tick prevention in dogs and cats, have been practice-changing when used off-label for the treatment of demodicosis in dogs and cats. Isoxazolines are GABA receptor antagonists leading to paralysis and subsequent death of insects. These medications have resulted in quicker resolution of skin symptoms. There has been a rapid rise in the use of these compounds, which means there is a new chemical in the shared environment that could leave a residue, though whether that holds risk for humans or other animals is as of yet, unknown. 

Next up, we explored a powerful but simple tool in One Health: asking the question, “Do dogs get atopic dermatitis?” It turns out, they absolutely do! And, currently, naturally occurring canine atopic dermatitis (AD) is likely the most established large animal model (i.e. non-mouse model) of human disease in dermatology. By identifying these similarities we can ask how looking to “man’s best friend” can tell us a lot about our own skin. Dr. Charles Bradley, a veterinary dermatopathologist at the University of Pennsylvania School of Veterinary Medicine and Dr. Elizabeth Grice, a microbiologist in the Department of Dermatology at the University of Pennsylvania, shared results from their collaboration characterizing the skin microbiome (genetic analysis of the microbial species, in this case bacterial communities, present on the skin) of dogs with AD. What they found mirrored the findings in human pediatric AD, previously characterized by Dr. Heidi Kong’s group at the NIH. By researching the skin microbiome of dogs, we may learn more about ways we can better predict disease progression and novel treatment strategies that could easily translate to healthier skin for humans. This opens the doors for translational research opportunities that go beyond “the mouse trap.” By using large animal models, like dogs, who naturally suffer from similar conditions as humans and who share the same household environment, it’s likely we can derive an even better understanding of how a given treatment strategy would perform for our own skin problems. This approach has the power to improve the heath of both species: a “win-win.”

Last up at the podium, a [physician] dermatologist and scientist, Dr. Brian Kim, the Co-Director for the Center for the Study of Itch at Washington University in St. Louis gave us a preview of his lab’s recent breakthroughs, accepted for publication in the journal Cell. His lab has identified that classical molecules ascribed to the immune system, IL-4 receptor alpha and JAK1, are also functional in the nervous system and critically mediate itch. Human patients that are on drugs to block these molecules enjoy a dramatic improvement in their symptom of itch. He anticipates by designing drugs that are more selective against these neuronal pathways, the paradigm will change when it comes to treating humans with chronic itch.

Dr. Kim’s talk was the perfect segue for Dr. Morris to discuss the veterinary [medical] experience using such targeted systemic therapies for the treatment of pruritus and atopic dermatitis in canines. Having patients covered in fur limits the use of topical therapies, first line approaches for treating atopic dermatitis in humans. Thus, veterinarians are 5-6 years ahead of human dermatology in using these treatment strategies. Dr. Morris discussed the JAK-1 inhibitor, oclacitinib, in treating his patients with these conditions. He then told the audience about lokivetmab, a caninized monoclonal antibody against IL-31, a mediator of itch through neuronal pathways. He provided examples of success in dogs who failed therapy with oclacitinib and discussed some limitations of IL-31 inhibitors, namely that they are good at decreasing the symptom of pruritus but do not have a good anti-inflammatory effect and may not be the answer for dogs who suffer from recurrent pyoderma. Future research collaborations between veterinarians and physician scientists to improve the treatment for chronic itch and atopic dermatitis will result in a better understanding of pathophysiology and treatment responses for humans and canines alike. This is truly the spirit of One Health.

References:

Beugnet F, Halos L, et al. Efficacy of oral afoxolaner for the treatment of canine generalized demodicosis. Parasite (2016) 23:14.

Bradley CW, Morris DO, Rankin SC, Cain CL, Misic AM, Houser T, et al. Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis. J Invest Dermatol. 2016;136(6):1182-90.

Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol 2015; 26: 171–e35.

Fourie JJ, Liebenberg JE, et al. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasites & Vectors. (2015) 8:187.

Gadeyne C, Little P, King VL, et al. Efficacy of oclacitinib (Apoquel) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol 2014; 25: 512–e86.

Gassel M, Wolf C, et al. The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod 𝛾-aminobutyric acid- and 𝐿-glutamate-gated chloride channels and insecticidal/acaricidal activity. Insect Biochemistry and Molecular Biology (2014) 45:111.

Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013;24:48-e12.

Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850-9.

Little PR, King VL, Davis KR, et al. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and cyclosporine for the control of atopic dermatitis in client-owned dogs.  Vet Dermatol 2015; 26: 23–e8.

Michels GM, Ramsey DS, Walsh KF, et al. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis. Vet Dermatol 2016; 27: 478–e129.

Mizuno T, Kanbayashi S, Okawa T, et al. Molecular cloning of canine interleukin-31 and its expression in various tissues. Vet Immunol Immunopathol 2009;131:140-3.

Weber T, Selzer PM. Isoxazolines: A novel chemotype highly effective on ectoparasites. Chem Med Chem 2016;11:270-6.


One health approach recognized in China's national science magazine - Friday, August 04, 2017

One health approach recognized in China's national science magazine

 

Human health and animal health are intimately related and the one-health approach is the only way to tackle emerging infectious diseases in a globalized world.”

 

Gregory C. Gray, MD, MPH, FIDSA

Duke Medicine

Professor, Division of Infectious Diseases, Global Health Institute, & Nicholas School of the Environment, Duke University

DUMC Box 102359, Durham, NC 27710

Tel: +1-919-684-1032

Duke-NUS Medical School, Singapore

Professor, Program in Emerging Infectious Diseases

8 College Road, Singapore 169857

Tel: +65-16-7666

Duke Kunshan University, China

Professor, Global Health

No. 8 Duke Avenue, Kunshan, Jiangsu, China 215316

Tel: +86-400-892-0508

Duke One Health: http://sites.globalhealth.duke.edu/dukeonehealth/      Email: Gregory.gray@duke.edu

See: “One world, one health: combating infectious diseases in the age of globalization”: National Science Review, Volume 4, Issue 3, 1 May 2017, Pages 493–499.

Note: Dr. Gray is a member of the One Health Initiative team’s Advisory Board http://www.onehealthinitiative.com/advBoard.php.


Strengthening the Implementation of One Health Principles - Chatham House - Thursday, August 03, 2017

Chatham House

 

An independent policy institute with a mission to help build a sustainably secure, prosperous and just world. 

Strengthening the Implementation of One Health Principles

This project aims to assess the potential benefits of establishing One Health platforms and centres of excellence in both high–income and low- and middle-income settings.

Please see https://www.chathamhouse.org/about/structure/global-health-security/strengthening-implementation-one-health-principles-project


 
One Health Initiative
Home | About One Health | Mission Statement | One Health News | AVMA Task Force Report | One Health Newsletter |
Publications | Supporters | Supporter Endorsements | Upcoming Events | Contact Us